Ethical Compliance
INNOVA CAPTAB
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
medium
Revenue
0.3%
Debt
18.3%
Liquidity
6.6%
Revenue
Debt
Liquidity
0.3%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Other Income | ₹8.76 |
| drugs and pharmaceutical products | ₹1,076.96 |
| Other Operating Revenue | ₹4.35 |
Questionable
INR Crores
Non Compliant
INR Crores
| Interest income | ₹3.73 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹3.73 |
| Total: | ₹3.73 |
| Total Revenue: | ₹1,093.79 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹3.73
₹1,093.79
= 0.3%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
